Feature | Mammography | October 30, 2017

FDA Warns Thermograms Are No Substitute for Mammograms

Agency responds to recent information that health centers are providing misleading information that thermograms are a proven alternative to regular screening mammography

FDA Warns Thermograms Are No Substitute for Mammograms

October 30, 2017 — The U.S. Food and Drug Administration (FDA) last week issued a release reminding patients that mammography is still the most effective breast cancer screening test. According to the agency, proper breast cancer screening lets healthcare providers check for cancer even before there may be signs and symptoms of the disease.

In the release, the FDA said it has received reports from healthcare providers and patients that some health centers are providing information that can mislead patients into believing that thermography — a type of test that shows patterns of heat and blood flow on or near the surface of the body — is a proven alternative to mammography. The agency said, however, it is not aware of any scientific evidence to support these claims.

Indeed, thermography has not been shown to be effective as a standalone test for either breast cancer screening or diagnosis in detecting early-stage breast cancer, the agency concluded.

“Plenty of evidence shows that mammography is still the most effective screening method for detecting breast cancer in its early, most treatable stages,” said Helen J. Barr, M.D., director of the Division of Mammography Quality Standards in the FDA’s Center for Devices and Radiological Health. “You should not rely solely on thermography for the screening or diagnosis of breast cancer.” 

The FDA regulates the medical devices used for breast cancer screening. About 1 in 8 women will be diagnosed with breast cancer sometime in their lives, according to the National Cancer Institute, part of the National Institutes of Health. Rarely, men also can have breast cancer. But there has been a decline in breast cancer deaths in recent years, and one reason is because cancers have been detected earlier through mammography, according to the American Cancer Society.

In fact, according to the FDA, the greatest danger from thermography is that those who opt for this method instead of mammography may miss the chance to detect cancer at its earliest stage.

Thermography has only been cleared by the FDA as an adjunctive tool for use alongside a primary test like mammography. Patients who undergo a thermography test alone should not be reassured of the findings because the device was not cleared to be used other than with another testing method like mammography. The FDA provides more information about mammography for patients — including how it works and how to find a certified facility — on its website.

Moreover, some websites claim that thermography can find breast cancer years before it would be detected through other methods and have unproven claims about improved detection of cancer in dense breasts. The FDA is aware of no evidence that supports these claims, the release stated.

The FDA has taken regulatory action (including issuing warning letters) against healthcare providers and thermography manufacturers who try to mislead patients into believing that the thermography can take the place of mammography. To protect the public health, the FDA’s regulatory action can include scheduling a regulatory meeting, sending a warning letter or other correspondence, an establishment inspection, and judicial actions.

The FDA said it continues to monitor this situation.

Some women have sought out thermography because it is painless and does not require exposure to radiation. The FDA advises that if patients are worried about how a mammogram feels, they should talk to their healthcare provider about what they can expect. A mammogram can be uncomfortable for the person being screened because it briefly presses down on the breast to flatten out the breast tissue and increase the clarity of the X-ray image. The agency also has a section on its website about what patients can expect during a mammogram.

The agency also recommends patients should talk to their healthcare provider if they have specific questions about mammography, including questions about when and how frequently they should be screened. As a rule, patients should also call their healthcare provider if they notice any change in either of their breasts such as a lump, thickening or nipple leakage, or changes in how the nipple looks.

For more information: www.fda.gov

Related Content

UT Dallas study aims to advance thermography for monitoring tumors

Adolfo Lozano, PhD'20, works on a proof-of-concept computer model of the thermal properties of breast cancer. He and other UT Dallas researchers aim to improve digital thermal imaging as a tool for monitoring cancer and its treatment. Image courtesy of The University of Texas at Dallas

News | Breast Imaging | September 09, 2020
September 9, 2020 — ...
The solution leverages image transfer speed, tag morphing, and multi-vendor PACS capabilities to enable comprehensive image visualization and analysis at the point of care
News | Breast Imaging | September 03, 2020
September 3, 2020 — Based on its recent analysis of the global breast imaging workstation industry, Frost & Sulli
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms. The best algorithm proved to be as accurate as the average radiologist.
News | Breast Imaging | August 28, 2020
August 28, 2020 — Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the
Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, announced improvements to the Brevera Breast Biopsy System with CorLumina Imaging Technology, the world’s first and only breast biopsy solution to combine vacuum-assisted tissue acquisition, real-time imaging verification and advanced post-biopsy handling in one, integrated system.
News | Breast Biopsy Systems | August 28, 2020
August 28, 2020 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s heal
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
August 20, 2020— For most women with early breast cancer
The results of an online questionnaire of 609 breast cancer survivors in the U.S. suggest that nearly half of patients experienced delays in care during the early weeks of the COVID-19 pandemic.

Getty Images

News | Coronavirus (COVID-19) | August 19, 2020
August 19, 2020 — The...